tm logo
ZYGEL
Live/Pending
THIRD EXTENSION - GRANTED

granted

on 27 Jun 2024

Last Applicant/ Owned by

80 W. Lancaster Avenue, Suite 300

Devon

PA

19333

Serial Number

97235095 filed on 24th Jan 2022

Registration Number

N/A

Correspondent Address

Sarah Anne Keefe

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

ZYGEL

Pharmaceutical preparations for the treatment of human and veterinary diseases and disorders, namely, addiction, auditory diseases and disorders, autism, autoimmune diseases and disorders, anxiety, bone diseases and disorders, cardiovascular diseases and disorders, cardiopulmonary diseases and disorders, cognitive diseases and disorders, dermatological diseases and disorders, diabetic diseases and Read More

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations for the treatment of human and veterinary diseases and disorders, namely, addiction, auditory diseases and disorders, autism, autoimmune diseases and disorders, anxiety, bone diseases and disorders, cardiovascular diseases and disorders, cardiopulmonary diseases and disorders, cognitive diseases and disorders, dermatological diseases and disorders, diabetic diseases and disorders, endocrine diseases and disorders, gastroenterological diseases and disorders, genetic diseases and disorders, genitourinary diseases and disorders, hepatological diseases and disorders, hormonal diseases and disorders, infectious diseases and disorders, immunological diseases and disorders, inflammatory diseases and disorders, metabolic diseases and disorders, movement diseases and disorders, muscular diseases and disorders, musculoskeletal diseases and disorders, neurodegenerative diseases and disorders, neurodevelopmental diseases and disorders, oncological diseases and disorders, ophthalmic diseases and disorders, pain, post-traumatic stress, pulmonary diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, rheumatological diseases and disorders, psychiatric diseases and disorders, seizure diseases and disorders, sexual dysfunction, speech disorders and diseases, traumatic brain injury, and viral diseases and disorders; Pharmaceutical preparations for the treatment of fragile x syndrome, substance related addiction, autism and autism spectrum disorders, epilepsy, seizure diseases and disorders, anxiety, aphasias, stuttering, post-traumatic stress disorder; all of the foregoing specifically excluding narcolepsy and management of sleep disorders


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 97235095

Mark Type

No Service/Collective Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
27th Jun 2024SOU EXTENSION 3 FILED
27th Jun 2024SOU EXTENSION 3 GRANTED
27th Jun 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
27th Jun 2024SOU TEAS EXTENSION RECEIVED
03rd Feb 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
01st Feb 2024SOU EXTENSION 2 GRANTED
01st Feb 2024SOU EXTENSION 2 FILED
01st Feb 2024SOU TEAS EXTENSION RECEIVED
08th Jul 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06th Jul 2023SOU EXTENSION 1 GRANTED